JUNIPER PHARMACEUTICALS INC Deferred Tax Assets, Valuation Allowance
JUNIPER PHARMACEUTICALS INC had Deferred Tax Assets, Valuation Allowance of $39.07 million as of 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2018-03-09
- 2017-12-31: Deferred Tax Assets, Valuation Allowance $39.07M.
- 2016-12-31: Deferred Tax Assets, Valuation Allowance $58.98M.
- 2015-12-31: Deferred Tax Assets, Valuation Allowance $61.99M; Deferred Tax Assets, Valuation Allowance as first filed $60.85M.
- 2014-12-31: Deferred Tax Assets, Valuation Allowance $59.59M; Deferred Tax Assets, Valuation Allowance as first filed $58.27M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2017-12-31 | $39.07M 10-K · filed 2018-03-09 | |
| 2016-12-31 | $58.98M 10-K · filed 2018-03-09 | |
| 2015-12-31 | $61.99M 10-K · filed 2017-03-07 | $60.85M 10-K · filed 2016-03-10 |
| 2014-12-31 | $59.59M 10-K/A · filed 2016-11-14 | $58.27M 10-K · filed 2015-03-18 |
| 2013-12-31 | $63.18M 10-K · filed 2015-03-18 | $63.18M 10-K · filed 2014-03-05 |
| 2012-12-31 | $62.26M 10-K · filed 2014-03-05 | |
| 2011-12-31 | $59.18M 10-K · filed 2013-03-14 |